Cumberland Pharmaceuticals (CPIX) Amortization - Intangibles (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Amortization - Intangibles across 17 years of filings, most recently posting $7151.0 for Q2 2026.

• In Q2 2026, Amortization - Intangibles rose 23.96% year-over-year to $7151.0; the TTM figure through Jun 2026 stood at $3.3 million (down 7.61% YoY), while the FY2025 annual figure was $4.0 million, down 15.03% from the prior year.
• Amortization - Intangibles came in at $7151.0 for Q2 2026 at Cumberland Pharmaceuticals, down from $1.2 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $4.5 million in Q4 2023 to a low of $5769.0 in Q2 2025.
• Average Amortization - Intangibles over 5 years is $1.2 million, with a median of $1.1 million recorded in 2023.
• Year-over-year, Amortization - Intangibles jumped 890.6% in 2023 and tumbled 99.48% in 2025.
• Over 5 years, Amortization - Intangibles stood at $458222.0 in 2022, then jumped by 890.6% to $4.5 million in 2023, then sank by 67.85% to $1.5 million in 2024, then tumbled by 30.57% to $1.0 million in 2025, then sank by 99.29% to $7151.0 in 2026.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were $7151.0 in Q2 2026, $1.2 million in Q1 2026, and $1.0 million in Q4 2025.